Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Serco Group PLC Remuneration Information 2018

Jul 2, 2018

5273_rns_2018-07-02_19cdc2fc-123d-437e-af9a-6dd35027b133.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2786T

Serco Group PLC

02 July 2018

2 July 2018                                                                                                    

Serco Group plc      

LEI: 549300PT2CIHYN5GWJ21

Block Listing Six Monthly Return

Name of company: Serco Group plc
Name of scheme: a. Long Term Incentive Scheme

b. Savings Related Share Option Scheme

c. Executive Option Plan
Period of return: From: 1 January 2018 To: 30 June 2018
Balance of unallotted securities under scheme(s) from previous return: a. 237,415 ordinary 2p shares

b. 66,303 ordinary 2p shares

c. 56,363 ordinary 2p shares
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): a. Nil ordinary 2p shares

b. Nil ordinary 2p shares

c. Nil ordinary 2p shares
Less:  Number of securities issued/allotted under scheme(s) during period: a. Nil ordinary 2p shares

b. Nil ordinary 2p shares

c. Nil ordinary 2p shares
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: a. 237,415 ordinary 2p shares

b. 66,303 ordinary 2p shares

c. 56,363 ordinary 2p shares
Name of contact: Stuart Heydon
Telephone number of contact: 01256 745900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRSSEFFEFASEIW